Ireland· IE-PA-EU/1/21/1606/001
Yselty 100 mg film-coated tablets
A linzagolix product containing linzagolix choline, registered in Ireland by Theramex Ireland Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Linzagolix is registered in 12 of 19 countries.
Countries holding a registration under ATC H01CC04 (linzagolix), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Linzagolix · ATC H01CC04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of linzagolix costs, country by country.
Normalised to the WHO defined daily dose (0.13 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linzagolix · price per daily dose (0.13 g)
USD · FX 28 Sept 2026
- IT Italy$6.85
- ES Spain$5.81
The record
At a glance
HPRA (Ireland)- Active substance
- Linzagolix Choline
- Manufacturer
- Theramex Ireland Limited
- Country
- Ireland (IE)
- ATC code
- H01CC04
- ATC class
- Linzagolix
- Defined daily dose
- 0.13 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1606/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Linzagolix in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6f7e287-6088-4866-a29f-35bc6261cf28 GET /v1/drugs/c6f7e287-6088-4866-a29f-35bc6261cf28?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"H01CC04"
],
"strength": null,
"pa_number": "EU/1/21/1606/001",
"substances": [
"Linzagolix Choline"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "14/06/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about linzagolix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.